Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.

Berta Mosleh,Karin Schelch,Thomas Mohr,Thomas Klikovits,Christina Wagner,Lukas Ratzinger,Yawen Dong,Katharina Sinn,Alexander Ries,Walter Berger,Bettina Grasl-Kraupp,Konrad Hoetzenecker,Viktoria Laszlo,Balazs Dome,Balazs Hegedus,Marko Jakopovic,Mir Alireza Hoda,Michael Grusch

Thoracic cancer（2023）

引用 0|浏览20

暂无评分

摘要

FGF18 is not a prognostic biomarker in PM. Its role in PM tumor biology and the clinical significance of decreased plasma FGF18 in PM patients warrant further investigation.

查看译文

关键词

biomarker, FGF18, fibroblast growth factor 18, pleural mesothelioma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要